RecruitingPhase 3NCT07188584

Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer

Studying Nasopharyngeal carcinoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Ming-Yuan Chen
Intervention
Reduced-Target Radiotherapy(radiation)
Enrollment
166 target
Eligibility
18-70 years · All sexes
Timeline
2025 – 2031

Study locations (1)

Collaborators

Fifth Affiliated Hospital, Sun Yat-Sen University · Cancer Hospital of Guangxi Medical University · Fujian Cancer Hospital · The Affiliated Cancer Hospital of Xiangya School of Medicine Central South University · Sun Yat-Sen University Cancer Center · Affiliated Cancer Hospital & Institute of Guangzhou Medical University · Zhejiang Cancer Hospital · West China Hospital · Xiangya Hospital of Central South University · Affiliated Cancer Hospital of Shantou University Medical College · Yunnan Cancer Hospital · First Affiliated Hospital of Kunming Medical University · Wuzhou Red Cross Hospital · Zhongshan People's Hospital, Guangdong, China · Southern Medical University, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07188584 on ClinicalTrials.gov

Other trials for Nasopharyngeal carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Nasopharyngeal carcinoma →

← Back to all trials